Tuesday, September 29th, 2009
The US Food and Drug Administration (FDA) said the first clinical trial to test a new stem cell treatment for the fatal neurodegenerative disease ALS (amyotrophic lateral sclerosis) this month (ALS) can go ahead.
Posted in Contributors | Comments Off
Monday, September 28th, 2009
Regenerative medicine researchers at the University of Pittsburgh received two grants totaling more than $5 million from the National Institutes of Health (NIH) to explore new methods for cultivating replacement cells from existing tissues and organs. A $2.
Posted in Contributors | Comments Off
Saturday, September 26th, 2009
Researchers at Worcester Polytechnic Institute's (WPI) Life Sciences and Bioengineering Center at Gateway Park have received a total of $1.
Posted in Contributors | Comments Off